Preclinical development of cancer vaccines
Explore this paper's citation graph
Summary
In silico models have the potential ability to aid in searching of optimal treatment protocols, provided that they will be further tuned on experimental data, as a further result this preclinical study highlighted that kinetic of antibody response plays a major role in determining cancer prevention.
- Published
- 2009-05-05
- Cited by
- 0
- References
- 64
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:68889417
References
- Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator
- Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
- MONOCLONAL ANTIBODIES TO MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS: IV. A SERIES OF HYBRIDOMA CLONES PRODUCING ANTI‐H-2d ANTIBODIES AND AN EXAMINATION OF EXPRESSION OF H‐2d ANTIGENS ON THE SURFACE OF THESE CELLS
- The Combined Action of IL-15 and IL-12 Gene Transfer Can Induce Tumor Cell Rejection Without T and NK Cell Involvement1
- The intriguing role of polymorphonuclear neutrophils in antitumor reactions.
- Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
- Electro-Gene-Transfer: A New Approach for Muscle Gene Delivery
- Structural diversity of the classical H-2 genes: K, D, and L.
- The evolution of mathematical immunology
- MODELING TUMOR IMMUNOLOGY
- Implications of aging and self-tolerance on the generation of immune and antitumor immune responses.
- How antibodies act as natural adjuvants.
- Vaccines for tumour prevention
- Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
- Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models.
- Targeting the function of the HER2 oncogene in human cancer therapeutics
- The contribution of immunology to the rational design of novel antibacterial vaccines
- Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors
- The “A, B and C” of Her-2 DNA vaccine development
- Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.
Cited by
No citing papers recorded for this paper.
Related papers
No related papers recorded.